^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

EML4-ALK fusion + NFKBIA amplification + NKX2-1 amplification

i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor, EML4, EMAP Like 4, Restrictedly Overexpressed Proliferation-Associated Protein, Echinoderm Microtubule-Associated Protein-Like 4, Echinoderm Microtubule Associated Protein Like 4, Ropp 120, C2orf2, EMAP-4, EMAPL4, ROPP120, ELP120, NFKBIA, NFKB Inhibitor Alpha 2, NF-Kappa-B Inhibitor Alpha 2, IkappaBalpha 2, IKBA 2, Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells Inhibitor, Alpha 2, Major Histocompatibility Complex Enhancer-Binding Protein MAD3 3, I-Kappa-B-Alpha 3, IkB-Alpha 3, MAD-3, NFKBI 3, Nuclear Factor Of Kappa Light Chain Gene Enhancer In B-Cells, EDAID2, MAD3, NKX2-1, NK2 Homeobox 1, Thyroid Transcription Factor 1, TTF-1, TTF1, Thyroid-Specific Enhancer-Binding Protein, Homeobox Protein NK-2 Homolog A, Homeobox Protein Nkx-2.1, Thyroid Nuclear Factor 1, NKX2A, T/EBP, TITF1, NK-2 Homolog A, Benign Chorea, NKX2.1, NKX2-1, NMTC1, NK-2, TEBP, BCH, BHC
Entrez ID:
News
Trials